Enphysio Llc - Medicare Physical Therapist in Mililani, HI

Enphysio Llc is a medicare enrolled "Physical Therapist" provider in Mililani, Hawaii. Their current practice location is 94-181 Keaolani St, Mililani, Hawaii. You can reach out to their office (for appointments etc.) via phone at (509) 554-2209.

Enphysio Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Enphysio Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1205530011.

Contact Information

Enphysio Llc
94-181 Keaolani St,
Mililani, HI 96789-1823
(509) 554-2209
Not Available



Healthcare Provider's Profile

Full NameEnphysio Llc
TypeFacility
SpecialityPhysical Therapist
Location94-181 Keaolani St, Mililani, Hawaii
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1205530011
  • Provider Enumeration Date: 03/27/2023
  • Last Update Date: 03/27/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 1254798838
  • Enrollment ID: O20230613002977

Medical Identifiers

Medical identifiers for Enphysio Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205530011NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Enphysio Llc acts as a billing entity for following providers:
Provider NameTanner Crass
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1811446792
PECOS PAC ID: 6507145885
Enrollment ID: I20230613003059

News Archive

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

STARS study receives £1.7m funding to test effectiveness of TCM course

Disruptive behaviour in the classroom has an adverse effect on both teachers and pupils. It is a common source of stress for teachers and often a catalyst for leaving the profession. For pupils it may affect mental health, academic attainment and adversely impact on all children in a classroom.

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

The Indianapolis Star: "Indiana's hospitals and ambulatory surgery centers reported a decrease in preventable medical errors last year - including a 33 percent drop in the number of bed sores. Overall, 306 facilities reported 94 preventable medical errors in 2009, according to a report released Monday by the Indiana State Department of Health. That's down from 105 errors reported each year in 2008 and 2007. The 22 pressure ulcers, also called bed sores, reported for 2009 were the fewest since the state's medical-error reporting system began four years ago" (Lee, 8/31).

Melanoma patients may benefit from microRNA-26a replacement therapy

A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Enphysio Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Enphysio Llc
94-181 Keaolani St,
Mililani, HI 96789-1823

Ph: (509) 554-2209
Enphysio Llc
94-181 Keaolani St,
Mililani, HI 96789-1823

Ph: (509) 554-2209

News Archive

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

STARS study receives £1.7m funding to test effectiveness of TCM course

Disruptive behaviour in the classroom has an adverse effect on both teachers and pupils. It is a common source of stress for teachers and often a catalyst for leaving the profession. For pupils it may affect mental health, academic attainment and adversely impact on all children in a classroom.

Trubion Pharmaceuticals to present promising data from Phase 1 studies of SBI-087, SBI-087

Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.

Indiana reports fewer preventable medical errors; Kansas struggles to meet oral health needs

The Indianapolis Star: "Indiana's hospitals and ambulatory surgery centers reported a decrease in preventable medical errors last year - including a 33 percent drop in the number of bed sores. Overall, 306 facilities reported 94 preventable medical errors in 2009, according to a report released Monday by the Indiana State Department of Health. That's down from 105 errors reported each year in 2008 and 2007. The 22 pressure ulcers, also called bed sores, reported for 2009 were the fewest since the state's medical-error reporting system began four years ago" (Lee, 8/31).

Melanoma patients may benefit from microRNA-26a replacement therapy

A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer. MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent.

Read more News

› Verified 2 days ago


Physical Therapist in Mililani, HI

Dr. Jaymee Kau, PT, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 95-720 Lanikuhana Ave Ste 140, Mililani, HI 96789
Phone: 808-623-6244    Fax: 808-623-6414
Kira Hamamura,
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 95-720 Lanikuhana Ave Ste 140, Mililani, HI 96789
Phone: 808-623-6244    
Kara Meske, PT, DPT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 95-720 Lanikuhana Ave Ste 140, Mililani, HI 96789
Phone: 808-623-6244    
Anne Yee, M.S.P.T.
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 95-229 Halepule Pl, Mililani, HI 96789
Phone: 808-779-5623    Fax: 808-440-7274
Sierra Dee Downum, DPT, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 95-1105 Ainamakua Dr Ste 203, Mililani, HI 96789
Phone: 808-381-8947    Fax: 800-586-4356
Tammie Harada, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 95-720 Lanikuhana Ave, 140, Mililani, HI 96789
Phone: 808-623-6244    Fax: 808-623-6414
Kori Yamasaki, PT, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 95-720 Lanikuhana Ave Ste 140, Mililani, HI 96789
Phone: 808-623-6244    Fax: 808-623-6414

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.